Skip to main content

EFC1580 BOREAS: A randomized double blind placebo controlled parallel group 52wk study to assess the efficacy, safety, and tolerability of Dupilumab in patients with moderate to severe COPD w/Type 2

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Sanofi US

Start Date

June 19, 2019

End Date

June 30, 2024
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Sanofi US

Start Date

June 19, 2019

End Date

June 30, 2024